pubrio
Ascentage Pharma

Ascentage Pharma

China · Biotechnology Research

Pharmaceuticals

Biotechnology

Healthcare

Biotechnology Research

Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.

Company Insights
Company Overview

2009

Founded

Biotechnology Research

Industry

China

Location

2,994,644

Ranking

200 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Ascentage Pharma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​